𝔖 Bobbio Scriptorium
✦   LIBER   ✦

FOCUS on FOCIS: Combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer

✍ Scribed by Daniela Rožková; Hana Tišerová; Jitka Fučíková; Jan Lašt'ovička; Michal Podrazil; Hana Ulčová; Vít Budínský; Jana Prausová; Zdeněk Linke; Ivo Minárik; Anna Šedivá; Radek Špíšek; Jiřina Bartůňková

Book ID
113540745
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
674 KB
Volume
131
Category
Article
ISSN
1090-2341

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II study of oral idarubicin as a
A Phase II study of oral idarubicin as a treatment for metastatic hormone-refractory prostate carcinoma with special focus on prostate specific antigen doubling time
✍ Hans-Peter Schmid; Rudolf Maibach; Juerg Bernhard; Franz Hering; Silvia Hanselma 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 2 views

## Background: Treatment of hormone-refractory prostate carcinoma with chemotherapy is purely palliative, and reported response rates have been low. at the time this study was conducted, there was an urgent need for a trial using potentially efficacious drugs, with quality of life (ql), and serial